Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Glioma × Hematologic Tests × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 10 Lung Neoplasms 8 Colorectal Neoplasms 7 Prostatic Neoplasms 6 Breast Neoplasms 5 Rectal Neoplasms 3 Polycystic Ovary Syndrome 3 Neoplasm Metastasis 3 Colonic Neoplasms 3 Stomach Neoplasms 2 Smoking Cessation 2 Motor Activity 2 Lymphoma 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Leukemia 2 Endometrial Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Venous Thromboembolism 1 Vaginal Neoplasms 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer 1 Testicular Germ Cell Tumor 1 Stroke 1 Skin Neoplasms 1 Sezary Syndrome 1 Retroviridae Infections 1 Pulmonary Disease, Chronic Obstructive 1 Prostate Cancer Metastatic 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

Temozolomide 99 Magnetic Resonance Spectroscopy 46 Bevacizumab 46 Radiotherapy 41 Irinotecan 23 Blood Specimen Collection 15 Aminolevulinic Acid 15 Surgical Procedures, Operative 13 Radiation 13 Carboplatin 13 Nivolumab 12 fluorodopa F 18 10 Radiotherapy, Intensity-Modulated 10 Radiosurgery 10 Carmustine 10 pembrolizumab 9 Topotecan 9 Surveys and Questionnaires 8 Specimen Handling 8 Magnetic Resonance Imaging 8 Erlotinib Hydrochloride 8 Biopsy 8 poly ICLC 7 Standard of Care 7 Filgrastim 7 Everolimus 7 Etoposide 7 Drug Therapy 7 Cyclophosphamide 7 ribociclib 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00985036 2012-04-24

Vascular Endothelial Growth Factor (VEGF) Levels in Brain Tumor Patients

Marquette General Health System

Glioma, Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡